Pediatric ENT Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), By Region, And Segment Forecasts, 2024 - 2030

Pediatric ENT Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), By Region, And Segment Forecasts, 2024 - 2030

Pediatric ENT Market Growth & Trends

The global pediatric ENT market size is anticipated to reach at USD 10.17 billion by 2030 and is projected to grow at a CAGR of 5.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. There is an increasing emphasis on early diagnosis and treatment of ENT disorders in children. This awareness drives parents and healthcare providers to seek out advanced diagnostic devices and treatment options, further propelling market growth.

Recent advancements in cochlear implants for pediatric patients include the introduction of the Cochlear Nucleus 8 Sound Processor, which received FDA approval for use in children aged 9 to 24 months in November 2022. This processor is noteworthy for being the most powerful and smallest Behind-The-Ear (BTE) cochlear implant sound processor available, and it has Bluetooth LE Audio technology, allowing direct audio connectivity to consumer electronics. This innovation aims to enhance the listening experience for children by automatically adjusting to environmental changes and reducing background noise during conversations.

Themarket is experiencing growth, significantly influenced by recent FDA approvals and initiatives aimed at enhancing the availability of medical devices specifically designed for children. In December 2023, Acclarent became the first and only company to receive FDA clearance for a new treatment option for children requiring repeat ear tubes.

Pediatric ENT Market Report Highlights

• The diagnostic ENT devices segment led the market with the largest revenue share of 57.15% in 2023. The hearing implant segment is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the increasing preference for cochlear implants as non-invasive methods.
• North America dominated the market with the revenue share of 34.14% in 2023, owing to improving digital health infrastructure, rising healthcare expenditure, and presence of major ENT device manufacturers.
• The FDA is actively promoting the development and approval of pediatric medical devices, recognizing the unique needs of children. This includes increasing the number of devices labeled for pediatric use and involving pediatric experts in advisory panels to ensure safety and efficacy for younger populations.
• In August 2023, Phonak launched new advancements for its Lumity platform to better cater to individuals with untreated hearing loss in one ear and teens, children, and adults those with severe-to-severe hearing loss.

Please note The report will be delivered in 4-8 business days upon order notification.